Beta-lactam allergy risk stratification in a maternity population in Australia: Scope for allergy de-labelling.
Wirawan JeongShahad SalehSharon HeapVi PhamLaura LeungSushena KrishnaswamyPublished in: The Australian & New Zealand journal of obstetrics & gynaecology (2024)
Beta-lactam allergies were inaccurately documented in more than one third of the maternity patients included in our study. As such, education of maternity care providers about the importance of accurate allergy history taking remains an urgent unmet need. Furthermore, allergy assessment and de-labelling during pregnancy should be considered in maternity patients to optimise antibiotic prescribing and to improve maternal and neonatal health outcomes.